SOAM
ONC

SBI Okasan Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

SBI Okasan Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493K Hold
1,700
– – 0.02% 215
2026
Q1 		$483K Hold
1,700
– – 0.02% 201
2025
Q4 		$528K Buy
+1,700
New +$556K 0.03% 186

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SBI Okasan Asset Management's ONC Position: Q2 2026 in Review

SBI Okasan Asset Management held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 1,700 shares worth $493K. The position accounts for 0.02% of the portfolio, ranked #215.

SBI Okasan Asset Management first reported a position in ONC in Q4 2025 and has held it in 3 quarters since. The position peaked at $528K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • SBI Okasan Asset Management held 1,700 shares of BeOne Medicines Ltd worth $493K as of Q2 2026.
  • SBI Okasan Asset Management left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up 0.02% of SBI Okasan Asset Management's portfolio in Q2 2026, its #215 holding.
  • SBI Okasan Asset Management first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 3 quarters since.
  • SBI Okasan Asset Management's BeOne Medicines Ltd position peaked at $528K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on SBI Okasan Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.